R&D News | pharmaphorum

News

Lilly pauses COVID-19 antibody trial after factory hits trou...

Eli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found serious quality control problems at the plant, according to press reports.

News

J&J's late-stage COVID-19 vaccine trial halted after 'unexpl...

Johnson & Johnson has paused further dosing in its COVID-19 vaccine clinical trial following an “unexplained illness” in a study participant.

News

Chord gets $16m to challenge Alexion with oral NMOSD drug

Swiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will be used to progress a repurposed drug for rare disease neuromyelitis optica

News

New CEO Mortazavi takes UK biotech e-therapeutics into gene ...

UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gen

News

Businessmen trading stocks online. Stock brokers looking at graphs, indexes and numbers on multiple computer screens. Colleagues in discussion in traders office. Business success concept.

UK biotech sector sets new record with more than £1bn invest...

There has been a well-publicised boom in biotech investment during the pandemic, and the UK is no exception, with a record £1 billion raised in the third quarter.

News

Data sets up ulcerative colitis expansion for BMS’ MS drug Z...

Bristol-Myers Squibb’s Zeposia (ozanimod) is already tipped for blockbuster sales in its first indication – multiple sclerosis – and new data in ulcerative colitis suggests they could climb

Lilly pauses COVID-19 antibody trial after factory hits trou...

J&J's late-stage COVID-19 vaccine trial halted after 'unexpl...

Chord gets $16m to challenge Alexion with oral NMOSD drug

New CEO Mortazavi takes UK biotech e-therapeutics into gene ...

UK biotech sector sets new record with more than £1bn invest...

Data sets up ulcerative colitis expansion for BMS’ MS drug Z...

Why everyone should care about longevity, with Boyang Wang

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks